Ambystoma Genetic Stock Center
- Institution
- UNIVERSITY OF KENTUCKY, KY
- Principal investigator
- Stephen Randal Voss
- Funding
- $70K
- Duration
- 2015–2030
Moonbase score
Still being scored
Abstract
APPLIED RESEARCH COMPONENT - PROJECT SUMMARY This component addresses the significance and need to generate new assays and approaches for disease monitoring within the AGSC and beyond, and the need to generate and centralize information for diagnosing and treating axolotl diseases. Next generation 16S rRNA sequencing will be performed to increase breadth of pathogen monitoring and generate baseline microbial data in support of microbiome research, both of which will better ensure the health and reproducibility of AGSC axolotl lines. Additionally, an axolotl disease manual will be developed to provide a reference that axolotl labs can use to monitor pathogens and diagnose common axolotl diseases. The manual will include protocols, assays, and treatments curated from the literature and developed in house. Accomplishment of this sub aim will provide an essential resource for characterizing lesions in diseased and genetically modified axolotls that serve as models of human disease.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF KENTUCKY
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of KentuckyReviewed
Ambystoma Genetic Stock Center
Stephen Randal Voss · $640K · 2015–2030
- NIH · University of KentuckyNot yet scored
Ambystoma Genetic Stock Center
Stephen Randal Voss · $327K · 2015–2030
- NIH · University of KentuckyNot yet scored
Ambystoma Genetic Stock Center
Stephen Randal Voss · $244K · 2015–2030